{"id":"W4404237915","doi":"10.1093/neuonc/noae165.0654","title":"IMMU-62. INVIGORATING EFFECTOR IMMUNE CELLS WITH HIGHLY SELECTIVE IL-2R AGONISTS AND POTENTIAL SYNERGY WITH TUMOR TARGETING THERAPEUTICS FOR TREATMENT OF GLIOBLASTOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Effector; Immune system; Cancer research; Medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001231501,0.0003892376,0.0002909076,0.0002339149,0.00006743457,0.0002577456,0.0001400313,0.0002234792,0.001010827],"category_scores_gemma":[0.00004031911,0.00007949452,0.0002352215,0.0001021392,0.0001252788,0.0001164516,0.0001745237,0.0004313936,0.0003365891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001500038,"about_ca_system_score_gemma":0.0002094325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002461509,"about_ca_topic_score_gemma":0.0006693626,"domain_scores_codex":[0.9999474,0.000009794509,0.000004467273,0.000007349177,0.00001210727,0.00001881775],"domain_scores_gemma":[0.9999804,0.000002194478,0.000004565305,0.000001618533,0.000001996992,0.00000920062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001112365,0.0006103867,0.0002516766,0.0002183647,0.00002473564,0.0001626324,0.00004141477,0.0007791928,0.9592288,0.0004726829,0.0006360517,0.03646169],"study_design_scores_gemma":[0.001424988,0.0184661,0.005050555,0.0000629644,0.0001550209,0.0008658559,0.00005780969,0.00448847,0.9402181,0.0002889101,0.02889597,0.00002521201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779165,0.01165268,0.003871017,0.0003869187,0.0001848653,0.0002315343,0.0003611663,0.0002188676,0.005176408],"genre_scores_gemma":[0.9883592,0.004458517,0.00298314,0.0002135128,0.00005833126,0.0001517767,0.0004845429,0.00001558946,0.003275351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001010827,"threshold_uncertainty_score":0.00338161,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006984292440468937,"score_gpt":0.2409440363658122,"score_spread":0.2339597439253432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}